Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index; 14 of the 37 sources its claims cite were checked for support.

Polyphenol Microbial Metabolites Exhibit Gut and Blood–Brain Barrier Permeability and Protect Murine Microglia against LPS-Induced Inflammation

Open access

Abstract

Increasing evidence supports the beneficial effects of polyphenol-rich diets, including the traditional Mediterranean diet, for the management of cardiovascular disease, obesity and neurodegenerative diseases. However, a common concern when discussing the protective effects of polyphenol-rich diets against diseases is whether these compounds are present in systemic circulation in their intact/parent forms in order to exert their beneficial effects in vivo. Here, we explore two common classes of dietary polyphenols, namely isoflavones and lignans, and their gut microbial-derived metabolites for gut and blood-brain barrier predicted permeability, as well as protection against neuroinflammatory stimuli in murine BV-2 microglia. Polyphenol microbial metabolites (PMMs) generally showed greater permeability through artificial gut and blood-brain barriers compared to their parent compounds. The parent polyphenols and their corresponding PMMs were evaluated for protective effects against lipopolysaccharide-induced inflammation in BV-2 microglia. The lignan-derived PMMs, equol and enterolactone, exhibited protective effects against nitric oxide production, as well as against pro-inflammatory cytokines (IL-6 and TNF-α) in BV-2 microglia. Therefore, PMMs may contribute, in large part, to the beneficial effects attributed to polyphenol-rich diets, further supporting the important role of gut microbiota in human health and disease prevention.

Overview

CoChat Summary

## TL;DR

This study tested whether polyphenol parent compounds and their gut microbial metabolites can cross artificial gut and blood–brain barriers and reduce LPS-induced inflammation in murine BV-2 microglia. The microbial metabolites enterolactone (EL) and equol (EQ) generally showed greater permeability and the strongest anti-inflammatory effects among the metabolites tested.

## Key findings

  • In SwissADME, all six compounds tested were predicted to have high gut absorbance; EQ, DAI, and EL were predicted to be BBB permeable.
  • In gut PAMPA, SECO, GEN, DAI, EL, and EQ showed high permeability across pH 5.0, 6.2, and 7.4, while ED had the lowest permeability of all test compounds.
  • In BBB PAMPA, EL and EQ showed high permeability, with -log Pe values of 3.97 ± 0.14 and 3.52 ± 0.20, respectively; GEN and DAI were intermediate, while SECO and ED were low.
  • In BV-2 microglia, LPS increased nitric oxide species to 41.5 ± 5.6 μM and TNF-α to 687.7 ± 8.0 pg/mL and IL-6 to 103.7 ± 3.6 pg/mL; GEN produced the strongest anti-inflammatory response, reducing nitric oxide by 68% at 20 μM and IL-6 by 80.4% at 20 μM, while EL was the most effective lignan-derived metabolite.

## Methods

  • The study combined in silico prediction (SwissADME) with in vitro parallel artificial membrane permeability assays (PAMPA) to assess gut and BBB passive permeability of parent polyphenols and microbial metabolites.
  • Murine BV-2 microglia were exposed to compounds before LPS stimulation (1 μg/mL for 23 h), with compound concentrations of 20 or 10 μM depending on the compound.
  • Cell viability was measured by CellTiter-Glo; nitric oxide was quantified by Griess assay; IL-6 and TNF-α were measured by ELISA; statistical analysis used ANOVA with Dunnett’s or Tukey’s tests.

## Limitations

  • The paper states that PAMPA only considers passive transport, so it does not capture active transport or other in vivo influences on permeability.
  • The experiments were performed in artificial membrane systems and in a murine microglial cell line, so in vivo human bioavailability and neuroprotective effects are not directly demonstrated in the paper.
  • The text makes evident that some compounds were tested at different concentrations and only selected metabolites were advanced to the cell assays; this limits direct comparability across all compounds.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/metabo9040078

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Overview of the polyphenol isoflavones and lignan parent compounds and their respective polyphenol microbial metabolites produced by gut microflora. (Genistein = GEN, daidzein = DAI, equol = EQ, secoisolariciresinol = SECO, enterodiol = ED, enterolactone = EL).
Figure 1 Overview of the polyphenol isoflavones and lignan parent compounds and their respective polyphenol microbial metabolites produced by gut microflora. (Genistein = GEN, daidzein = DAI, equol = EQ, secoisolariciresinol = SECO, enterodiol = ED, enterolactone = EL).CC BY · PubMed Central
Figure 2 Parallel artificial membrane permeability assay (PAMPA) gut passive permeability at three relevant pH levels: 5.0 (A), 6.2 (B), and 7.4 (C). Controls verapamil, antipyrine and ranitidine exhibit high, medium and low penetrability, respectively. Ketoprofen shows variable permeability with pH change.
Figure 2 Parallel artificial membrane permeability assay (PAMPA) gut passive permeability at three relevant pH levels: 5.0 (A), 6.2 (B), and 7.4 (C). Controls verapamil, antipyrine and ranitidine exhibit high, medium and low penetrability, respectively. Ketoprofen shows variable permeability with pH change.CC BY · PubMed Central
Figure 3 Assessment of blood–brain barrier passive permeability of polyphenols determined by PAMPA. Positive (verapamil), intermediate (corticosterone) and low (theophylline) permeability controls.
Figure 3 Assessment of blood–brain barrier passive permeability of polyphenols determined by PAMPA. Positive (verapamil), intermediate (corticosterone) and low (theophylline) permeability controls.CC BY · PubMed Central
Figure 4 Effects of isoflavones against LPS-induced oxidative stress in BV-2 murine microglia. Isoflavones exhibited no cytotoxic effects in murine microglia (A). Isoflavones (20 µM and 10 µM) reduce nitric oxide production, as determined by the Griess Reagent (B). Isoflavones inhibited the production of the pro-inflammatory cytokines, TNF-α (C) and IL-6 (D), in murine microglia. All data expressed as mean ± standard error (n ≥ 3), significance was reported by analysis of variance (ANOVA) followed with Dunnett multiple comparison testing. Significance as compared with control p ≤ 0.0001 (####); as compared with LPS, p ≤ 0.03 (*), p ≤ 0.002 (**), p ≤ 0.0002 (***) and p ≤ 0.0001 (****).
Figure 4 Effects of isoflavones against LPS-induced oxidative stress in BV-2 murine microglia. Isoflavones exhibited no cytotoxic effects in murine microglia (A). Isoflavones (20 µM and 10 µM) reduce nitric oxide production, as determined by the Griess Reagent (B). Isoflavones inhibited the production of the pro-inflammatory cytokines, TNF-α (C) and IL-6 (D), in murine microglia. All data expressed as mean ± standard error (n ≥ 3), significance was reported by analysis of variance (ANOVA) followed with Dunnett multiple comparison testing. Significance as compared with control p ≤ 0.0001 (####); as compared with LPS, p ≤ 0.03 (*), p ≤ 0.002 (**), p ≤ 0.0002 (***) and p ≤ 0.0001 (****).CC BY · PubMed Central
Figure 5 Effects of lignans in murine microglia cells. Lignans were evaluated for cytotoxicity in BV-2 (A). Effect of lignan treatment (10 μM) on nitric oxide production, as determined by the Griess Reagent (B). Lignans reduce the production of pro-inflammatory cytokines in murine microglia, TNF-α (C) and IL-6 (D). All data expressed as mean ± standard error (n ≥ 3), significance was reported by analysis of variance (ANOVA) followed with Dunnett multiple comparison testing. Significance as compared with control p ≤ 0.0001 (####); as compared with LPS, p ≤ 0.002 (**), p ≤ 0.0002 (***) and p ≤ 0.0001 (****).
Figure 5 Effects of lignans in murine microglia cells. Lignans were evaluated for cytotoxicity in BV-2 (A). Effect of lignan treatment (10 μM) on nitric oxide production, as determined by the Griess Reagent (B). Lignans reduce the production of pro-inflammatory cytokines in murine microglia, TNF-α (C) and IL-6 (D). All data expressed as mean ± standard error (n ≥ 3), significance was reported by analysis of variance (ANOVA) followed with Dunnett multiple comparison testing. Significance as compared with control p ≤ 0.0001 (####); as compared with LPS, p ≤ 0.002 (**), p ≤ 0.0002 (***) and p ≤ 0.0001 (****).CC BY · PubMed Central

Verification

Claims the paper makes

11 Valid · 1 Not valid · 15 Not checked · 49 Own results and interpretations

28 more claims

Create a free account to see all 76 claims and to verify the 3 references still open.

See all claims — free account
  • Probably not a substantial claim. 22
  • It may state two separate claims as one. 28
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 57 references

Research works printed but not linked: 1

  1. Gupta, R.C. (2016). Isoflavones: Toxicology aspects and efficacy. Nutraceuticals: Efficacy, Safety, and Toxicity, Elsevier Inc.

Cited by

See all 101

Metadata

Authors
Johnson, S. L., Kirk, R. D., DaSilva, N. A., Ma, H., Seeram, N. P., & Bertin, M. J.
Affiliations
University of Rhode Island (US)
Corresponding author
  • Seeram, Navindra P.
  • Bertin, Matthew J.
Venue
Metabolites
Publisher
MDPI AG
Published
2019-04-19
Volume
9
Issue
4
Pages
78
ISSN
2218-1989 (ISSN-L)
OpenAlex
W2940306410
Cited by
101
References
57
Citations by year
2026: 15 · 2025: 7 · 2024: 18 · 2023: 16 · 2022: 16 · 2021: 13 · 2020: 13 · 2019: 3
FWCI
5.63
Type
journal article
Language
en
Open access
Locations
  • Metabolites (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Journal of Media Literacy Education (submittedVersion, cc-by)
  • Digital Commons - URI (University of Rhode Island) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute of General Medical Sciences (P20GM103430)
Topics
  • Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
gut microbiota, blood-brain barrier permeability, isoflavones, lignans, equol, enterolactone, microglia, lipopolysaccharide-induced neuroinflammation, nitric oxide, inflammatory cytokines, BV-2 cells, neuroprotection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Polyphenol Microbial Metabolites Exhibit Gut and Blood–Brain Barrier Permeability and Protect Murine Microglia against LPS-Induced Inflammation. https://app.cochat.ai/papers/10.3390/metabo9040078
The paper
Johnson, S. L., Kirk, R. D., DaSilva, N. A., Ma, H., Seeram, N. P., & Bertin, M. J. (2019). Polyphenol Microbial Metabolites Exhibit Gut and Blood–Brain Barrier Permeability and Protect Murine Microglia against LPS-Induced Inflammation. Metabolites. https://doi.org/10.3390/metabo9040078

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.